Zu den Inhalten springen

Molecular Imaging Research Center

The main focus of AMIR is multimodal imaging for pre-clinical and translational research. Our work  is dedicated to the fusion of cellular research and clinical projects  in development and implementation of novel and advanced techniques for small animal imaging. Modalities used include in vivo magnetic resonance imaging (MRI), small animal Ultrasound, optical imaging and µCT with a focus on photon counting techniques. Further goals are to  provide cutting edge technology and research tools in cooperation together with our partners in the University of Freiburg.

CAIRnet is a coordinated effort from research teams of the Universities of Freiburg, Aachen, and Tübingen. The partners are operating research centers offering a comprehensive set of advanced small animal imaging techniques for a broad range of applications. CAIRnet has been recomended as an Euro-BioImaging Node. Euro-BioImaging is a pan-European infrastructure project whose mission is to build a distributed imaging infrastructure across Europe.

Within the SFB 850 AMIR runs the core facility project Z2 "Imaging" in cooperation with the Dept. of Haematology and Oncology and the Dept. of Nuclearmedicine. It offers small animal imaging support and advice employing bioluminescence, micro PET and MRI techniques.

BrainLinks-BrainTools aims to develop medical technology that directly interacts with the nervous system. For this purpose, it unites the life sciences, engineering, and clinical applications. BrainLinks-BrainTools is a Cluster of Excellence, funded since 2012 within the German Excellence Initiative

NANOTRANSMED is a European project, led by a french-german-swiss consortium and cofinanced by the INTERREG VA Upper Rhine Programme. NANOTRANSMED enables French, German and Swiss scientists to develop together applications and innovations in nanomedicine. On the basis of new approaches, made possible by the use of nano-objects (probes, smart implants…), it is now possible to create innovative and efficient solutions meeting major issues regarding patients’ care. The NANOTRANSMED consortium focuses in particular on issues concerning early, reliable and fast diagnosis but also personalized treatment of diseases such as cancers and inflammation as well as issues regarding nosocomial infections contracted by 5% of hospitalized patients.


The Research Program Translational Cancer Research ,  is based on the German Cancer Research Center (DKFZ) within the National Center for Tumor Diseases (NCT) Heidelberg  and  has  its  focus on the transfer of approaches in the  prevention,  diagnosis  and  treatment of cancer to clinical application.